Position in LLY
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$4,662,184
+$1,087,039 QoQ
Shares Held
3,887
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
1.84%
of 13F equity value
Holder Rank
#1,768
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 1%
Shared 0%
None 99%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BOURNE LENT ASSET MANAGEMENT INC holds $19,951,025 across 7 Drug Manufacturers - General names. LLY ranks #2 (23.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BMY |
Bristol Myers Squibb Co
|
117,066 | $6,745,342 | |
| 2 | LLY |
ELI LILLY & Co
This page
|
3,887 | $4,662,184 | |
| 3 | AMGN |
Amgen Inc
|
9,860 | $3,570,503 | |
| 4 | JNJ |
Johnson & Johnson
|
12,206 | $3,099,957 | |
| 5 | PFE |
Pfizer Inc
|
36,275 | $873,502 | |
| 6 | MRK |
Merck & Co., Inc.
|
4,357 | $559,874 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
3,480 | $439,663 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,662,184 | 3,887 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $3,575,145 | 3,887 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $4,188,028 | 3,897 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $2,992,486 | 3,922 | Shares | Sole | 2025-12-15 | |
| 2025-06-30 | $3,045,623 | 3,907 | Shares | Sole | 2025-07-08 | |
| 2025-03-31 | $3,226,830 | 3,907 | Shares | Sole | 2025-04-14 | |
| 2024-12-31 | $3,016,204 | 3,907 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $3,461,367 | 3,907 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $3,520,117 | 3,888 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $3,023,152 | 3,886 | Shares | Sole | 2024-04-12 | |
| 2023-12-31 | $2,265,227 | 3,886 | Shares | Sole | 2024-01-19 | |
| 2023-09-30 | $2,098,029 | 3,906 | Shares | Sole | 2023-10-19 | |
| 2023-06-30 | $1,841,215 | 3,926 | Shares | Sole | 2023-07-18 | |
| 2023-03-31 | $1,365,437 | 3,976 | Shares | Sole | 2023-04-25 | |
| 2022-12-31 | $1,472,871 | 4,026 | Shares | Sole | 2023-01-24 | |
| 2022-09-30 | $1,301,807 | 4,026 | Shares | Sole | 2022-11-01 | |
| 2022-06-30 | $1,321,561 | 4,076 | Shares | Sole | 2022-07-27 | |
| 2022-03-31 | $1,167,244 | 4,076 | Shares | Sole | 2022-04-26 | |
| 2021-12-31 | $1,125,872 | 4,076 | Shares | Sole | 2022-01-20 | |
| 2021-09-30 | $941,759 | 4,076 | Shares | Sole | 2021-10-20 | |
| 2021-06-30 | $935,523 | 4,076 | Shares | Sole | 2021-07-28 | |
| 2021-03-31 | $761,478 | 4,076 | Shares | Sole | 2021-04-23 | |
| 2020-12-31 | $688,191 | 4,076 | Shares | Sole | 2021-01-27 | |
| 2020-09-30 | $634,857 | 4,289 | Shares | Sole | 2020-10-19 | |
| 2020-06-30 | $704,168 | 4,289 | Shares | Sole | 2020-07-20 | |
| 2020-03-31 | $728,696 | 5,253 | Shares | Sole | 2020-04-17 | |
| No filing history on record for this holder in this stock. | ||||||